Transient Ischemic Attack Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Transient Ischemic Attack clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

DeathStrokeTransient Ischemic Attack+2 more
Bakulev Scientific Center of Cardiovascular Surgery158 enrolled1 locationNCT06253000
Recruiting

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

DiabetesCarotid Artery StenosisHyperlipidemia+6 more
Tang-Du Hospital200 enrolled1 locationNCT06935279
Recruiting
Not Applicable

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Atrial FibrillationHypertensionIschemic Stroke+2 more
Jukka Putaala405 enrolled4 locationsNCT03710902
Recruiting
Not Applicable

Integrated Approach in Frail Older People with Atrial Fibrillation

Heart FailureDiabetes MellitusHypertension+7 more
Heart Care Foundation1,250 enrolled50 locationsNCT06775028
Recruiting
Not Applicable

Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke

Atrial FibrillationTransient Ischemic AttackIschemic Stroke, Cryptogenic
Technical University of Munich400 enrolled1 locationNCT06005233
Recruiting
Phase 2

European Blood Pressure Intensive Control After Stroke

Ischemic StrokeTransient Ischemic Attack
University College Dublin142 enrolled1 locationNCT04647292
Recruiting
Phase 4

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Diabetes Mellitus, Type 2Stroke (CVA) or Transient Ischemic Attack
University of Washington50 enrolled1 locationNCT05780905
Recruiting

Translational Immunodiagnostics in Stroke (TrImS)

Atrial FibrillationAcute Ischemic StrokeCardioembolic Stroke+9 more
The University of Hong Kong650 enrolled1 locationNCT05300997
Recruiting

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Quality of LifeStressCaregiver Burden+7 more
University of Zurich680 enrolled1 locationNCT06443268